APA

Reghellin V., Donnici L., Fenu S., Berno V., Calabrese V., Pagani M., Abrignani S., Peri F., De Francesco R. & Neddermann P. (20150707). NS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase IIIα complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranes. : Antimicrobial agents and chemotherapy.

Chicago

Reghellin V, Donnici L, Fenu S, Berno V, Calabrese V, Pagani M, Abrignani S, Peri F, De Francesco R and Neddermann P. 20150707. NS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase IIIα complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranes. : Antimicrobial agents and chemotherapy.

Harvard

Reghellin V., Donnici L., Fenu S., Berno V., Calabrese V., Pagani M., Abrignani S., Peri F., De Francesco R. and Neddermann P. (20150707). NS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase IIIα complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranes. : Antimicrobial agents and chemotherapy.

MLA

Reghellin V, Donnici L, Fenu S, Berno V, Calabrese V, Pagani M, Abrignani S, Peri F, De Francesco R and Neddermann P. NS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase IIIα complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranes. : Antimicrobial agents and chemotherapy. 20150707.